Pharmaceutical

NewBiologix licenses cell line technology to Recipharm Advanced Bio

NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide pharma companies access to Xcell-Eng-HEK293.

May 10, 2025 - 06:00
NewBiologix licenses cell line technology to Recipharm Advanced Bio
NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide pharma companies access to Xcell-Eng-HEK293.
Read the original article

Tags:

Previous Article

Bavarian Nordic shares rise 7% following strong Q1 for vaccine sales

Next Article

FDA chief Martin Makary sets June deadline for genAI rollout

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Watch: P-value, an important measurement in clinical trials, explained

Watch: P-value, an important measurement in clinical tr...

Mar 20, 2023

STAT+: Dutch health minister won’t cover a Gilead cancer drug due to the cost

STAT+: Dutch health minister won’t cover a Gilead cance...

Mar 30, 2023

US FDA approves Pharming’s Joenja to treat APDS

US FDA approves Pharming’s Joenja to treat APDS

Mar 27, 2023